Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Conference News ACC 2019

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Caitlin E. Cox

March 25, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Conference News ACC 2019

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Yael L. Maxwell

March 20, 2019

Presentation ACC 2019

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Presenter: Suzanne V. Arnold

March 18, 2019

News Opinion Editor's Corner ACC 2019

Live From New Orleans: Days 2 and 3 at ACC 2019

Shelley Wood

March 18, 2019

Presentation ACC 2019

1-Year Outcomes from the CardioMEMS Post-Approval Study

Presenter: David M. Shavelle

March 18, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Presentation ACC 2019

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Presenter: Federico M. Asch

March 17, 2019

Presentation ACC 2019

Results from the PANACHE Phase 2b RCT

Presenter: Sanjiv J. Shah

March 17, 2019

Presentation ACC 2019

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Presenter: Adam D. DeVore

March 17, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Conference News ACC 2019

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Caitlin E. Cox

March 16, 2019

News Conference News ACC 2019

Apple Watch May Detect A-fib in the General Population, but at What Cost?

Yael L. Maxwell

March 16, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News

TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

April 10, 2001

Video

» Interview

ACC 2019: PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial

March 18, 2019

Advertisement

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Amlodipine the Key Component in Dual BP Therapy in Sub-Saharan Africa: CREOLE

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial

Live From New Orleans: Days 2 and 3 at ACC 2019

1-Year Outcomes from the CardioMEMS Post-Approval Study

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT trial

Results from the PANACHE Phase 2b RCT

Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Spectrum of Shock Treated in Contemporary US Practice: Clues From the CCCTN

Apple Watch May Detect A-fib in the General Population, but at What Cost?

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

ACC 2019: PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content